Community pharmacy practice and challenges amid the coronavirus disease-19 pandemic: A survey in southwest Ethiopia

Community pharmacy practice and challenges amid the coronavirus disease-19 pandemic: A survey in southwest Ethiopia

The coronavirus disease-19 (COVID-19) pandemic has challenged and forced the community pharmacies across the world to take various measures to prevent its spread. This survey was conducted to assess the community pharmacy practice and challenges in Ethiopia amid the coronavirus disease-19 pandemic. The survey was conducted involving 67 community pharmacy professionals in Jimma and Mizan-Aman towns in the period from November 25 to December 10, 2020. A checklist was used for the data collection, and descriptive analysis was conducted using SPSS V.22. In this study, druggists were higher in proportion than pharmacists (64.2% vs. 35.8%). Of the stock of the COVID19 infection protection supplies, facemask was well-stocked (73.1%), whereas most respondents (73.1%) reported no stock of face shields. Practicing a distance of >1 meter from the customers (85.1%) and keeping hand hygiene (83.6%) were among the measures reported to prevent cross-infection. Above two-third of the respondents reported an increase in verbal queries of the COVID-19 information (68.7%). Financial implication (89.6%) and staff cross-infection risk (89.6%) were the major worries reported by the respondents. In this study, some of the sociodemographic information were identified to affect the COVID-19 precautionary measures and challenges. In conclusion, the present study revealed problem with availability of some of the COVID-19 prevention supplies, like face shields (73.1%), requiring effort to avail. An increase in COVID-19 related queries from customers was also reported. The COVID-19 precautionary measures, such as practicing hand hygiene, physical distancing, and others were reported. The reported financial and other challenges of the COVID-19 needs mitigation measures.

___

  • [1] WHO Coronavirus (COVID-19) Dashboard 2021. https://covid19.who.int/, (accessed on 22 May 2021).
  • [2] Hoti K, Jakupi A, Hetemi D, Raka D, Hughes J, Desselle S. Provision of community pharmacy services during COVID 19 pandemic: a cross sectional study of community pharmacists' experiences with preventative measures and sources of information. Int J Clin Pharm. 2020; 42(4): 1197-1206.
  • [3] Gregory PAM, Austin Z. COVID-19: How did community pharmacies get through the first wave? Can Pharm J (Ott). 2020; 153(5): 243-251.
  • [4] Alves da Costa F, Lee V, Leite SN, Murillo MD, Menge T, Antoniou S. Pharmacists reinventing their roles to effectively respond to COVID-19: a global report from the international pharmacists for anticoagulation care taskforce (iPACT). J Pharm Policy Pract. 2020; 13(1): 1-3.
  • [5] Bukhari N, Rasheed H, Nayyer B, Babar Z-U-D. Pharmacists at the frontline beating the COVID-19 pandemic. J Pharm Policy Pract. 2020; 13(1): 1-4.
  • [6] Ahmad A, Alkharfy KM, Alrabiah Z, Alhossan A. Saudi Arabia, pharmacists and COVID-19 pandemic. J Pharm Policy Pract. 2020;13: 41.
  • [7] Bragazzi NL, Mansour M, Bonsignore A, Ciliberti R. The Role of Hospital and Community Pharmacists in the Management of COVID-19: Towards an Expanded Definition of the Roles, Responsibilities, and Duties of the Pharmacist. Pharmacy (Basel, Switzerland). 2020; 8(3): 1-15.
  • [8] Hamed SH. Community Pharmacy Practice During COVID-19 Pandemic: A Perspective From the Middle East. JQSH. 2020; 3(3): 109-114.
  • [9] Hayden JC, Parkin R. The challenges of COVID-19 for community pharmacists and opportunities for the future. Ir J Psychol Med. 2020; 37(3): 198-203.
  • [10] Kasahun GG, Kahsay GM, Asayehegn AT, Demoz GT, Desta DM, Gebretekle GB. Pharmacy preparedness and response for the prevention and control of coronavirus disease (COVID-19) in Aksum, Ethiopia; a qualitative exploration. BMC Health Serv Res. 2020; 20(1): 913: 1-6.
  • [11] Tesfaye ZT, Yismaw MB, Negash Z, Ayele AG. COVID-19-Related Knowledge, Attitude and Practice Among Hospital and Community Pharmacists in Addis Ababa, Ethiopia. Integr Pharm Res Pract. 2020; 9: 105-112.
  • [12] Bahlol M, Dewey RS. Pandemic preparedness of community pharmacies for COVID-19. Res Social Adm Pharm. 2021; 17(1): 1888-1896.
  • [13] Zaidi STR, Hasan SS. Personal protective practices and pharmacy services delivery by community pharmacists during COVID-19 pandemic: Results from a national survey. Res Social Adm Pharm. 2021; 17(1): 1832-1837.
  • [14] Sum ZZ, Ow CJ. Community pharmacy response to infection control during COVID-19. A cross-sectional survey. Res Social Adm Pharm. 2021; 17(1): 1845-1852.
  • [15] Dzingirai B, Matyanga C, Mudzviti T, Siyawamwaya M, Tagwireyi D. Risks to the community pharmacists and pharmacy personnel during COVID-19 pandemic: perspectives from a low-income country. J Pharm Policy Pract. 2020; 13(1): 1-6.
  • [16] Hoti K, Jakupi A, Hetemi D, Raka D, Hughes J, Desselle S. Provision of community pharmacy services during COVID-19 pandemic: a cross sectional study of community pharmacists’ experiences with preventative measures and sources of information. Int J Clin Pharm. 2020; 42(4): 1197-1206.
  • [17] El-Hage W, Hingray C, Lemogne C, Yrondi A, Brunault P, Bienvenu T, et al. Health professionals facing the coronavirus disease 2019 (COVID-19) pandemic: What are the mental health risks? Encephale. 2020: 73-80.
  • [18] Ashiru-Oredope D, Chan AHY, Olaoye O, Rutter V. Needs assessment and impact of COVID-19 on pharmacy professionals in 31 commonwealth countries. J Pharm Policy Pract. 2020;13(1): 1-11.
  • [19] Lange M, Joo S, Couette P-A, De Jaegher S, Joly F, Humbert X. Impact on mental health of the COVID-19 outbreak among community pharmacists during the sanitary lockdown period. Ann Pharm Fr. 2020;78(6):459-463.
  • [20] Johnson A, Vincent B, Carson P, Skoy E. Prevalence of SARS-CoV-2 antibodies among North Dakota community pharmacy personnel: A seroprevalence survey. J Am Pharm Assoc. 2021: 127-132.
  • [21] Strand MA, Bratberg J, Eukel H, Hardy M, Williams C. Peer Reviewed: Community Pharmacists’ Contributions to Disease Management During the COVID-19 Pandemic. Prev Chronic Dis. 2020; 17: 1-8
  • [22] Cerbin-Koczorowska M, Waszyk-Nowaczyk M, Przymuszała P. Pharmacists’ Preparedness to Patients Education at the Time of Pandemic—A Cross-Sectional Study with an Example of SARS-CoV-2 Outbreak in Poland. Int J Environ Res Public Health. 2020; 17(18): 6659.
Journal of research in pharmacy (online)-Cover
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: Marmara Üniversitesi
Sayıdaki Diğer Makaleler

COVID-19 pandemic and the healthcare workers- The call of duty

Narendar KUMAR, Shaib MUHAMMAD, Geeta KUMARI, Razia SULTANA, Muhammad Saleh KHASKHELI, Jabbar ABBAS, Rafia TABASSUM, Sadaf Hayat LAGHARI

Pyrazine-chromene-3-carbohydrazide conjugates: Molecular docking and ADMET predictions on dualacting compounds against SARS-CoV-2 Mpro and RdRp

Arif MERMER, Serhii VAKAL

Hematological and inflammatory parameters in hospitalized patients with COVID‐19 infection in Chattogram, Bangladesh

Rakibul Hassan BULBUL, Giash UDDIN, Kazi Ishrak FAIYAZ, Mohammad Rashedul ISLAM, Ashraful ALAM, Shakeel AHMED, Zakir HOSSAIN, Mohammad Safiqul ISLAM, Mohammed LOKMAN

Evaluation of molnupiravir analogues as novel coronavirus (SARS-CoV-2) RNA-dependent RNA polymerase (RdRp) inhibitors – an in silico docking and ADMET simulation study

Tuğçe YEŞİL, İlkay KÜÇÜKGÜZEL, Necla KULABAŞ

The role of community pharmacists during the COVID-19 pandemic in the U.S.

Mehmed Bülend UĞUR, İrem Tutku ASLANBAY, Zeynep Sena MUŞ

Community pharmacy practice and challenges amid the coronavirus disease-19 pandemic: A survey in southwest Ethiopia

Behailu TEREFE, Mengist AWOKE, Dula DESSALEGN, Girma MAMO, Bezie KEBEDE, Temesgen MULUGETA

Effects of the Covid-19 pandemic on brain and behavior

Tayfun UZBAY

Molecular modelling studies to suggest novel scaffolds against SARS-CoV-2 target enzymes

Atilla AKDEMİR, Ş. Güniz KÜÇÜKGÜZEL, Ahmet Fatih ŞAHİN

Knowledge and attitudes of community pharmacists about COVID-19

Nilay AKSOY, Öyküm DEMİREL

Administration of systemic steroids during hospitalization does not improve the clinical outcome in patients with Covid-19

Hale Z. TOKLU, Ranjit BANWAIT, Sad ALQUADAN, Sarah WILSON, Dhaval UPADHYAY, Devina SINGH, Rima PATEL, Christopher BRAY